This study aimed to evaluate the efficacy of a diagnostic model integrating intratumoral and peritumoral radiomic features based on contrast-enhanced ultrasound (CEUS) for differentiation between carcinoma in situ (CIS) and invasive breast carcinoma (IBC). Consecutive cases confirmed by postoperative histopathological analysis were retrospectively gathered, comprising 143 cases of CIS from January 2018 to May 2024, and 186 cases of IBC from May 2022 to May 2024, totaling 322 patients with 329 lesion and complete preoperative CEUS imaging. Intratumoral regions of interest (ROI) were defined in CEUS peak-phase images deferring gray-scale mode, while peritumoral ROI were defined by expanding 2 mm, 5 mm, and 8 mm beyond the tumor margin for radiomic features extraction. Statistical and machine learning techniques were employed for feature selection. Logistic regression classifier was utilized to construct radiomic models integrating intratumoral, peritumoral, and clinical features. Model performance was assessed using the area under the curve (AUC). The model incorporating 5 mm peritumoral features with intratumoral and clinical data exhibited superior diagnostic performance, achieving AUCs of 0.927 and 0.911 in the training and test sets, respectively. It outperformed models based only on clinical features or other radiomic configurations, with the 5 mm peritumoral region proving most effective for lesions discrimination. This study highlights the significant potential of combined intratumoral and peritumoral CEUS radiomics for classifying CIS and IBC, with the integration of 5 mm peritumoral features notably enhancing diagnostic accuracy.

Cardiovascular diseases are the leading cause of death in the world, with coronary artery disease being the most prevalent. Coronary artery calcifications are critical biomarkers for cardiovascular disease, and their quantification via non-contrast computed tomography is a widely accepted and heavily employed technique for risk assessment. Manual segmentation of these calcifications is a time-consuming task, subject to variability. State-of-the-art methods often employ convolutional neural networks for an automated approach. However, there is a lack of studies that perform these segmentations with 3D architectures that can gather important and necessary anatomical context to distinguish the different coronary arteries. This paper proposes a novel and automated approach that uses a lightweight three-dimensional convolutional neural network to perform efficient and accurate segmentations and calcium scoring. Results show that this method achieves Dice score coefficients of 0.93 ± 0.02, 0.93 ± 0.03, 0.84 ± 0.02, 0.63 ± 0.06 and 0.89 ± 0.03 for the foreground, left anterior descending artery (LAD), left circumflex artery (LCX), left main artery (LM) and right coronary artery (RCA) calcifications, respectively, outperforming other state-of-the-art architectures. An external cohort validation also showed the generalization of this method's performance and how it can be applied in different clinical scenarios. In conclusion, the proposed lightweight 3D convolutional neural network demonstrates high efficiency and accuracy, outperforming state-of-the-art methods and showcasing robust generalization potential.

Breast cancer became the primary cause of cancer-related deaths among women year by year. Early detection and accurate prediction of breast cancer play a crucial role in strengthening the quality of human life. Many scientists have concentrated on analyzing and conducting the development of many algorithms and progressing computer-aided diagnosis applications. Whereas many research have been conducted, feature research on cancer diagnosis is rare, especially regarding predicting the desired features by providing and feeding breast cancer features into the system. In this regard, this paper proposed a Breast Cancer Prediction (RF-BCP) algorithm based on Random Forest by taking inputs to predict cancer. For the experiment of the proposed algorithm, two datasets were utilized namely Breast Cancer dataset and a curated mammography dataset, and also compared the accuracy of the proposed algorithm with SVM, Gaussian NB, and KNN algorithms. Experimental results show that the proposed algorithm can predict well and outperform other existing machine learning algorithms to support decision-making.

Clinical decision-making relies heavily on understanding relative positions of anatomical structures and anomalies. Therefore, for Vision-Language Models (VLMs) to be applicable in clinical practice, the ability to accurately determine relative positions on medical images is a fundamental prerequisite. Despite its importance, this capability remains highly underexplored. To address this gap, we evaluate the ability of state-of-the-art VLMs, GPT-4o, Llama3.2, Pixtral, and JanusPro, and find that all models fail at this fundamental task. Inspired by successful approaches in computer vision, we investigate whether visual prompts, such as alphanumeric or colored markers placed on anatomical structures, can enhance performance. While these markers provide moderate improvements, results remain significantly lower on medical images compared to observations made on natural images. Our evaluations suggest that, in medical imaging, VLMs rely more on prior anatomical knowledge than on actual image content for answering relative position questions, often leading to incorrect conclusions. To facilitate further research in this area, we introduce the MIRP , Medical Imaging Relative Positioning, benchmark dataset, designed to systematically evaluate the capability to identify relative positions in medical images.

Classification models that provide human-interpretable explanations enhance clinicians' trust and usability in medical image diagnosis. One research focus is the integration and prediction of pathology-related visual attributes used by radiologists alongside the diagnosis, aligning AI decision-making with clinical reasoning. Radiologists use attributes like shape and texture as established diagnostic criteria and mirroring these in AI decision-making both enhances transparency and enables explicit validation of model outputs. However, the adoption of such models is limited by the scarcity of large-scale medical image datasets annotated with these attributes. To address this challenge, we propose synthesizing attribute-annotated data using a generative model. We enhance the Diffusion Model with attribute conditioning and train it using only 20 attribute-labeled lung nodule samples from the LIDC-IDRI dataset. Incorporating its generated images into the training of an explainable model boosts performance, increasing attribute prediction accuracy by 13.4% and target prediction accuracy by 1.8% compared to training with only the small real attribute-annotated dataset. This work highlights the potential of synthetic data to overcome dataset limitations, enhancing the applicability of explainable models in medical image analysis.

Accurate segmentation of small lesions in Breast Dynamic Contrast-Enhanced MRI (DCE-MRI) is critical for early cancer detection, especially in high-risk patients. While recent deep learning methods have advanced lesion segmentation, they primarily target large lesions and neglect valuable longitudinal and clinical information routinely used by radiologists. In real-world screening, detecting subtle or emerging lesions requires radiologists to compare across timepoints and consider previous radiology assessments, such as the BI-RADS score. We propose LesiOnTime, a novel 3D segmentation approach that mimics clinical diagnostic workflows by jointly leveraging longitudinal imaging and BIRADS scores. The key components are: (1) a Temporal Prior Attention (TPA) block that dynamically integrates information from previous and current scans; and (2) a BI-RADS Consistency Regularization (BCR) loss that enforces latent space alignment for scans with similar radiological assessments, thus embedding domain knowledge into the training process. Evaluated on a curated in-house longitudinal dataset of high-risk patients with DCE-MRI, our approach outperforms state-of-the-art single-timepoint and longitudinal baselines by 5% in terms of Dice. Ablation studies demonstrate that both TPA and BCR contribute complementary performance gains. These results highlight the importance of incorporating temporal and clinical context for reliable early lesion segmentation in real-world breast cancer screening. Our code is publicly available at https://github.com/cirmuw/LesiOnTime

Intracranial aneurysms (IAs) are abnormal dilations of cerebral blood vessels that, if ruptured, can lead to life-threatening consequences. However, their small size and soft contrast in radiological scans often make it difficult to perform accurate and efficient detection and morphological analyses, which are critical in the clinical care of the disorder. Furthermore, the lack of large public datasets with voxel-wise expert annotations pose challenges for developing deep learning algorithms to address the issues. Therefore, we proposed a novel weakly supervised 3D multi-task UNet that integrates vesselness priors to jointly perform aneurysm detection and segmentation in time-of-flight MR angiography (TOF-MRA). Specifically, to robustly guide IA detection and segmentation, we employ the popular Frangi's vesselness filter to derive soft cerebrovascular priors for both network input and an attention block to conduct segmentation from the decoder and detection from an auxiliary branch. We train our model on the Lausanne dataset with coarse ground truth segmentation, and evaluate it on the test set with refined labels from the same database. To further assess our model's generalizability, we also validate it externally on the ADAM dataset. Our results demonstrate the superior performance of the proposed technique over the SOTA techniques for aneurysm segmentation (Dice = 0.614, 95%HD =1.38mm) and detection (false positive rate = 1.47, sensitivity = 92.9%).

Alzheimer's disease (AD) is accompanied by alterations in retinal vascular density (VD), but the mechanisms remain unclear. This study investigated the relationship among cerebral amyloid-β (Aβ) deposition, VD, and cognitive decline. We enrolled 92 participants, including 47 AD patients and 45 healthy control (HC) participants. VD across retinal subregions was quantified using deep learning-based fundus photography, and cerebral Aβ deposition was measured with ¹⁸F-florbetapir (¹⁸F-AV45) PET/MRI. Using the minimum bounding circle of the optic disc as the diameter (papilla-diameter, PD), VD (total, 0.5-1.0 PD, 1.0-1.5 PD, 1.5-2.0 PD, 2.0-2.5 PD) was calculated. Standardized uptake value ratio (SUVR) for Aβ deposition was computed for global and regional cortical areas, using the cerebellar cortex as the reference region. Cognitive performance was assessed with the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). Pearson correlation, multiple linear regression, and mediation analyses were used to explore Aβ deposition, VD, and cognition. AD patients exhibited significantly lower VD in all subregions compared to HC (p < 0.05). Reduced VD correlated with higher SUVR in the global cortex and a decline in cognitive abilities (p < 0.05). Mediation analysis indicated that VD influenced MMSE and MoCA through SUVR in the global cortex, with the most pronounced effects observed in the 1.0-1.5 PD range. Retinal VD is associated with cognitive decline, a relationship primarily mediated by cerebral Aβ deposition measured via ¹⁸F-AV45 PET. These findings highlight the potential of retinal VD as a biomarker for early detection in AD.

Recent advancements in large language models (LLMs) have led to multimodal LLMs (MLLMs), which integrate multiple data modalities beyond text. Although MLLMs show promise, there is a gap in the literature that empirically demonstrates their impact in healthcare. This paper summarizes the applications of MLLMs in healthcare, highlighting their potential to transform health practices. A rapid literature review was conducted in August 2024 using World Health Organization (WHO) rapid-review methodology and PRISMA standards, with searches across four databases (Scopus, Medline, PubMed and ACM Digital Library) and top-tier conferences-including NeurIPS, ICML, AAAI, MICCAI, CVPR, ACL and EMNLP. Articles on MLLMs healthcare applications were included for analysis based on inclusion and exclusion criteria. The search yielded 115 articles, 39 included in the final analysis. Of these, 77% appeared online (preprints and published) in 2024, reflecting the emergence of MLLMs. 80% of studies were from Asia and North America (mainly China and US), with Europe lagging. Studies split evenly between pre-built MLLMs evaluations (60% focused on GPT versions) and custom MLLMs/frameworks development with task-specific customizations. About 81% of studies examined MLLMs for diagnosis and reporting in radiology, pathology, and ophthalmology, with additional applications in education, surgery, and mental health. Prompting strategies, used in 80% of studies, improved performance in nearly half. However, evaluation practices were inconsistent with 67% reported accuracy. Error analysis was mostly anecdotal, with only 18% categorized failure types. Only 13% validated explainability through clinician feedback. Clinical deployment was demonstrated in just 3% of studies, and workflow integration, governance, and safety were rarely addressed. MLLMs offer substantial potential for healthcare transformation through multimodal data integration. Yet, methodological inconsistencies, limited validation, and underdeveloped deployment strategies highlight the need for standardized evaluation metrics, structured error analysis, and human-centered design to support safe, scalable, and trustworthy clinical adoption.

This study aimed to optimize the imaging time and image quality of T2WI-FS through the integration of Artificial Intelligence-Assisted Compressed Sensing (ACS) and respiratory triggering (RT). A prospective cohort study was conducted on one hundred thirty-four patients (99 males, 35 females; average age: 57.93 ± 9.40 years) undergoing liver MRI between March and July 2024. All patients were scanned using both breath-hold ACS-assisted T2WI (BH-ACS-T2WI) and respiratory-triggered ACS-assisted T2WI (RT-ACS-T2WI) sequences. Two experienced radiologists retrospectively analyzed regions of interest (ROIs), recorded primary lesions, and assessed key metrics including signal intensity (SI), standard deviation (SD), signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), motion artifacts, hepatic vessel clarity, liver edge sharpness, lesion conspicuity, and overall image quality. Statistical comparisons were conducted using Mann-Whitney U test, Wilcoxon signed-rank test and intraclass correlation coefficient (ICC). Compared to BH-ACS-T2WI, RT-ACS-T2WI significantly reduced average imaging time from 38 s to 22.91 ± 3.36 s, achieving a 40 % reduction in scan duration. Additionally, RT-ACS-T2WI demonstrated superior performance across multiple parameters, including SI, SD, SNR, CNR, motion artifact reduction, hepatic vessel clarity, liver edge sharpness, lesion conspicuity (≤5 mm), and overall image quality (P < 0.05). Notably, the lesion detection rate was slightly higher with RT-ACS-T2WI (94 %) compared to BH-ACS-T2WI (90 %). The RT-ACS-T2WI sequence not only enhanced image quality but also reduced imaging time to approximately 23 s, making it particularly beneficial for patients unable to perform prolonged breath-holding maneuvers. This approach represents a promising advancement in optimizing liver MRI protocols.